Concepedia

Frank Osterkamp

FO

16

Publications

982

Citations

14

H-Index

1999

Active since

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Humboldt-Universität zu Berlin

Clovis Oncology (United States)

Zentralklinik Bad Berka

Leibniz Institute for Neurobiology

Frank Osterkamp is an author at Charité - Universitätsmedizin Berlin specializing in medicine, pharmacology, and biochemistry.

Top concepts

Publications per year

1999–2024

16

Publications

16

Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using <sup>177</sup>Lu-FAP-2286: First-in-Humans Results

Richard P. Baum, Christiane Schuchardt, Aviral Singh et al. · Journal of Nuclear Medicine · 2021 · 287 citations · Full text

Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy

Dirk Zboralski, Aileen Hoehne, Anne Bredenbeck et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 230 citations · Full text

<sup>177</sup>Lu-3BP-227 for Neurotensin Receptor 1–Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results

Richard P. Baum, Aviral Singh, Christiane Schuchardt et al. · Journal of Nuclear Medicine · 2017 · 83 citations · Full text

Design and Synthesis of a New Class of Selective Integrin α5β1 Antagonists

Roland Stragies, Frank Osterkamp, Gunther Zischinsky et al. · Journal of Medicinal Chemistry · 2007 · 63 citations · Full text

, , +15

Proof of Therapeutic Efficacy of a<sup>177</sup>Lu-Labeled Neurotensin Receptor 1 Antagonist in a Colon Carcinoma Xenograft Model

Jörg Schulz, Martin Rohracker, Marvin Stiebler et al. · Journal of Nuclear Medicine · 2017 · 50 citations · Full text

Rows per page

1–5 of 16